Effectdossier · gearchiveerd kwartaal
EXAS
Exact Sciences Corporation · Healthcare · Medical - Diagnostics & Research
18Gevolgde houders
—Δ houders
42.26MGehouden aandelen
$1.79BGerapporteerde waarde
+0Nieuwe posities
−0Uitstappen
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2024
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q1 2026 | 1 | -143 | 11.48K | $1.20M | — | −144 |
| Q4 2025 | 146 | +2 | 107.45M | $10.91B | +5 | −2 |
| Q3 2025 | 23 | +1 | 95.08M | $5.20B | +1 | −1 |
| Q2 2025 | 20 | 0 | 105.61M | $5.61B | — | — |
| Q1 2025 | 17 | -2 | 51.51M | $2.23B | +1 | −3 |
| Q4 2024 | 19 | +2 | 51.81M | $2.91B | +3 | −1 |
| Q3 2024 | 16 | -2 | 41.47M | $2.82B | — | −2 |
| Q2 2024 | 18 | — | 42.26M | $1.79B | — | — |
Wie het bezit · Q2 2024
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 16.50M | — | $697.18M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passief) | 3.10M | — | $130.68M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 3.10M | — | $130.68M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Baillie Gifford ✦ | 1.43M | — | $60.27M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Baillie Gifford ✦ | 1.43M | — | $60.27M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Baillie Gifford ✦ | 1.43M | — | $60.27M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Baillie Gifford ✦ | 1.43M | — | $60.27M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Norges Bank ✦ (passief) | 1.24M | — | $52.48M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 1.19M | — | $50.07M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 1.19M | — | $50.07M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 674.86K | — | $28.51M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Glenview Capital ✦ | 629.46K | — | $26.59M | 0.6% | n/c | 1 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 510.70K | — | $21.58M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | PRIMECAP Management ✦ | 496.30K | — | $20.97M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 461.34K | — | $19.49M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 461.34K | — | $19.49M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | ARK Investment Management ✦ | 344.49K | — | $14.55M | 0.1% | n/c | 1 | SEC ↗ |
| 25 | Soros Fund Management ✦ | 225.00K | — | $9.51M | 0.3% | n/c | 1 | SEC ↗ |
| 26 | Point72 Asset Management ✦ | 195.77K | — | $8.27M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fisher Asset Management ✦ | 159.20K | — | $6.73M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 153.60K | — | $6.49M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 153.60K | — | $6.49M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 153.60K | — | $6.49M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 153.60K | — | $6.49M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Gotham Asset Management ✦ | 131.55K | — | $5.56M | 0.1% | n/c | 1 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 40.25K | — | $1.70M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | D. E. Shaw & Co. ✦ | 40.25K | — | $1.70M | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 9 houders, 64.35K aandelen, $4.50M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2024 ·
Methodologie ·
Verkrijg dit via de API